Steps forward for cancer precision medicine

Roberto Salgado; Helen Moore; John W.M. Martens; Tracy Lively; Shakun Malik; Ultan McDermott; Stefan Michiels; Jeffrey A. Moscow; Sabine Tejpar; Tawnya McKee; Denis Lacombe

doi:10.1038/nrd.2017.218

Steps forward for cancer precision medicine

Roberto Salgado, Helen Moore, John W.M. Martens, Tracy Lively, Shakun Malik, Ultan McDermott, Stefan Michiels, Jeffrey A. Moscow, Sabine Tejpar, Tawnya McKee, Denis Lacombe

Résultats de recherche: Contribution à un journal › !!Comment/debate

32 Citations (Scopus)

Résumé

The availability of targeted anticancer drugs and the relative affordability of genomic analyses has led to a growing expectation among patients with cancer that they can receive personalized treatment based on the genomic signature of their tumour. Here, we discuss some of the challenges and steps needed to bring such approaches into routine practice.

langue originale	Anglais
Pages (de - à)	1-2
Nombre de pages	2
journal	Nature Reviews Drug Discovery
Volume	17
Numéro de publication	1
Les DOIs	https://doi.org/10.1038/nrd.2017.218
état	Publié - 1 janv. 2018

Accès au document

10.1038/nrd.2017.218

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{880e8d8bce624d879eda87fd1aabbef0,

title = "Steps forward for cancer precision medicine",

abstract = "The availability of targeted anticancer drugs and the relative affordability of genomic analyses has led to a growing expectation among patients with cancer that they can receive personalized treatment based on the genomic signature of their tumour. Here, we discuss some of the challenges and steps needed to bring such approaches into routine practice.",

author = "Roberto Salgado and Helen Moore and Martens, {John W.M.} and Tracy Lively and Shakun Malik and Ultan McDermott and Stefan Michiels and Moscow, {Jeffrey A.} and Sabine Tejpar and Tawnya McKee and Denis Lacombe",

year = "2018",

month = jan,

day = "1",

doi = "10.1038/nrd.2017.218",

language = "English",

volume = "17",

pages = "1--2",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

number = "1",

}

TY - JOUR

T1 - Steps forward for cancer precision medicine

AU - Salgado, Roberto

AU - Moore, Helen

AU - Martens, John W.M.

AU - Lively, Tracy

AU - Malik, Shakun

AU - McDermott, Ultan

AU - Michiels, Stefan

AU - Moscow, Jeffrey A.

AU - Tejpar, Sabine

AU - McKee, Tawnya

AU - Lacombe, Denis

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The availability of targeted anticancer drugs and the relative affordability of genomic analyses has led to a growing expectation among patients with cancer that they can receive personalized treatment based on the genomic signature of their tumour. Here, we discuss some of the challenges and steps needed to bring such approaches into routine practice.

AB - The availability of targeted anticancer drugs and the relative affordability of genomic analyses has led to a growing expectation among patients with cancer that they can receive personalized treatment based on the genomic signature of their tumour. Here, we discuss some of the challenges and steps needed to bring such approaches into routine practice.

UR - http://www.scopus.com/inward/record.url?scp=85039808453&partnerID=8YFLogxK

U2 - 10.1038/nrd.2017.218

DO - 10.1038/nrd.2017.218

M3 - Comment/debate

C2 - 29170471

AN - SCOPUS:85039808453

SN - 1474-1776

VL - 17

SP - 1

EP - 2

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

IS - 1

ER -